Jireh BioPath is an R&D-driven biotechnology company focused on antiviral drug development. We also provide integrated preclinical research services spanning cell-based studies, histopathology, animal models, and molecular and cellular analyses.
In particular, we are developing first-in-class therapeutics targeting innate immune sensors, with the goal of addressing both infectious and inflammatory diseases. Through this differentiated approach, we aim to overcome the limitations of conventional therapies and establish broad-spectrum therapeutic strategies against emerging and re-emerging viral threats.
At Jireh BioPath, we go beyond simply conducting experiments. We work as a research partner, helping our clients define research objectives, optimize study strategies, and interpret results. Our PhD-level scientists are directly involved in study design and execution to deliver reliable data and reproducible results.
Drawing on our research experience across infectious diseases, inflammatory disorders, and other disease areas, we provide strategic and systematic support to help translate research into meaningful outcomes. Our integrated research capabilities, from cell-based assays to small-animal studies, enable efficient and comprehensive preclinical research.
We will continue to advance our scientific capabilities and innovative drug development to contribute to the growth of the biotechnology industry and the improvement of human health.
Thank you.
